Cover Image
市場調查報告書

嗅覺障礙:全球臨床實驗檢討

Olfactory Disorders Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 309551
出版日期 內容資訊 英文 49 Pages
訂單完成後即時交付
價格
Back to Top
嗅覺障礙:全球臨床實驗檢討 Olfactory Disorders Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月28日 內容資訊: 英文 49 Pages
簡介

本報告提供嗅覺障礙相關的臨床研究最新趨勢分析,提供您疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別進展,有潛力的贊助商,各企業研究機關研究之進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 嗅覺障礙
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量中,嗅覺障礙臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7國)臨床實驗數量:中樞神經系統臨床實驗數量中,嗅覺障礙臨床實驗數量所佔的比例

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的藥劑

臨床實驗簡介

  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Washington
    • University Hospitals of Leicester NHS Trust
    • National Hospital Organization
    • Wuhan General Hospital of Guangzhou Military Command
    • 琦玉醫科大學
    • 東京大學醫院
    • Alberta Health Services
    • Dresden University of Technology
    • Thomas Jefferson University
    • Medical University of Vienna

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2260CTIDB

GlobalData's clinical trial report, "Olfactory Disorders Global Clinical Trials Review, H2, 2014" provides data on the Olfactory Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Olfactory Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Olfactory Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Olfactory Disorders
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Olfactory Disorders to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Olfactory Disorders to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Drugs
    • Clinical Trial Overview of Top Institutes / Government
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • University Hospitals of Leicester NHS Trust
      • Clinical Trial Overview of University Hospitals of Leicester NHS Trust
      • National Hospital Organization
      • Clinical Trial Overview of National Hospital Organization
      • Wuhan General Hospital of Guangzhou Military Command
      • Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • The University of Tokyo Hospital
      • Clinical Trial Overview of The University of Tokyo Hospital
      • Alberta Health Services
      • Clinical Trial Overview of Alberta Health Services
      • Dresden University of Technology
      • Clinical Trial Overview of Dresden University of Technology
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Region, 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Olfactory Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Wuhan General Hospital of Guangzhou Military Command, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo Hospital, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*

List of Figures

  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Olfactory Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Olfactory Disorders to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Olfactory Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Olfactory Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Olfactory Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top